You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 5, November 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Levodopa-Induced Dyskinesias

Comparison in Parkinsonism-Dementia and Amyotrophic Lateral Sclerosis

Thomas N. Chase, MD; E. Michael Holden, MD; Jacob A. Brody, MD

Arch Neurol. 1973;29(5):328-330.


Abstract

The incidence of levodopa-induced dyskinesias in 20 Guamanian patients with parkinsonism-dementia (PD) was compared with that found in 14 Guamanians with amyotrophic lateral sclerosis (ALS), who were matched for dose and duration of drug exposure. While 55% of the PD patients developed abnormal involuntary movements during the first six months of treatment, none of the ALS patients manifested this complication. In PD patients no definite correlation could be documented between pretreatment parkinsonian severity or degree of response to levodopa and the appearance of dyskinesias. The results suggest that lesions of the type which produce Parkinson disease increase the susceptibility to levodopa-induced dyskinesias, but that apparently denervation supersensitivity alone does not account for this phenomenon.



Author Affiliations

Bethesda, Md

From the Neurology Unit, National Institute of Mental Health (Dr. Chase), and the Epidemiology Branch, National Institute of Neurological Disease and Stroke (Drs. Holden and Brody), Bethesda, Md.


Footnotes

Accepted for publication June 26, 1973.

Reprint requests to Neurology Unit, National Institute of Health, Clinical Center, 9000 Rockville Pike, Bethesda, MD 20014 (Dr. Chase).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
Thanvi et al.
Postgrad. Med. J. 2007;83:384-388.
ABSTRACT | FULL TEXT  

Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
Thanvi and Lo
Postgrad. Med. J. 2004;80:452-458.
ABSTRACT | FULL TEXT  

Early-Morning Dystonia: A Late Side Effect of Long-term Levodopa Therapy in Parkinson's Disease
Melamed
Arch Neurol 1979;36:308-310.
ABSTRACT  

A Neuroendocrine Study of Supersensitivity in Tardive Dyskinesia
Tamminga et al.
Arch Gen Psychiatry 1977;34:1199-1203.
ABSTRACT  

Choreoathetosis and Diphenylhydantoin Intoxication
Shuttleworth et al.
JAMA 1974;230:1170-1171.
ABSTRACT  

Inosiplex and Amyotrophic Lateral Sclerosis: Therapeutic Trial in Patients on Guam
Brody et al.
Arch Neurol 1974;30:322-323.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.